KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Retained Earnings: 2009-2025

Historic Retained Earnings for Neogenomics (NEO) over the last 16 years, with Sep 2025 value amounting to -$423.9 million.

  • Neogenomics' Retained Earnings fell 36.55% to -$423.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$423.9 million, marking a year-over-year decrease of 36.55%. This contributed to the annual value of -$325.8 million for FY2024, which is 31.87% down from last year.
  • As of Q3 2025, Neogenomics' Retained Earnings stood at -$423.9 million, which was down 6.84% from -$396.8 million recorded in Q2 2025.
  • Neogenomics' 5-year Retained Earnings high stood at $47.3 million for Q2 2021, and its period low was -$423.9 million during Q3 2025.
  • Over the past 3 years, Neogenomics' median Retained Earnings value was -$292.8 million (recorded in 2024), while the average stood at -$296.3 million.
  • As far as peak fluctuations go, Neogenomics' Retained Earnings spiked by 287.89% in 2021, and later plummeted by 972.23% in 2022.
  • Neogenomics' Retained Earnings (Quarterly) stood at -$14.8 million in 2021, then plummeted by 972.23% to -$159.1 million in 2022, then crashed by 55.30% to -$247.1 million in 2023, then slumped by 31.87% to -$325.8 million in 2024, then tumbled by 36.55% to -$423.9 million in 2025.
  • Its last three reported values are -$423.9 million in Q3 2025, -$396.8 million for Q2 2025, and -$351.7 million during Q1 2025.